Atlas Trials

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

RecordFirmDate
A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Orthopedic Surgery (NCT06901830)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2025-05-23
A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery (NCT06890533)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2025-05-14
Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder (NCT06975514)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2025-03-25
A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets (NCT06680531)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2024-08-31
A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects (NCT06671470)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2024-08-22
Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Severe Renal Impairment and Normal Renal Impairment (NCT06671444)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2024-06-03
Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Mild, Moderate and Normal Hepatic Impairment (NCT06671509)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2024-03-22
A Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery (NCT06680466)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2023-12-26
A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors (NCT06209385)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2023-08-11
A Phase 1 Study of YZJ-4729 Tartrate Injection in Healthy Chinese Subjects (NCT06681493)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2022-10-12
Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder (NCT05525637)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2021-12-17
Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder (NCT06680505)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2019-08-04
PK/PD Study of YZJ-1139 (NCT06685341)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2019-03-07
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants (NCT06673927)Shanghai Haiyan Pharmaceutical Technology Co., Ltd.2017-12-01

Track Shanghai Haiyan Pharmaceutical Technology Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.